Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Investigating the effect of variable interferon signaling on CD4+ T cells

Award Number: F31AI203423
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 02/25/2027
PERIOD OF PERFORMANCE END DATE: 02/24/2028

Group Awards By:

View Award Description

Investigating the effect of variable interferon signaling on CD4+ T cells - Project summary Inflammation underlies all immune responses, but it is a double-edged sword: too little impairs danger sensing, lymphocyte function, and memory formation, while too much drives cytotoxicity and immunopathology. Understanding its consequences is essential for optimizing immunity during infection, vaccination, and aging. My project examines how priming in an inflamed environment shapes lymphocyte differentiation, focusing on the effect of type I interferon (IFN-I) on CD4⁺ memory T cells. IFN-I is broadly induced during viral infection and is known to durably imprint interferon-related programs in memory B cells, yet its influence on CD4⁺ T cell memory differentiation is unclear. Defining how elevated inflammation affects CD4⁺ T cell differentiation and antibody production may reveal avenues to improve vaccine efficacy. Our lab has shown that memory CD4⁺ T cells retain distinct transcriptional signatures depending on whether their initial exposure was to SARS-CoV-2 vaccination or infection, with inflammation-primed cells enriched for IFN-I–related genes. Because IFN-I and broader inflammatory signals are stronger during infection than vaccination, we ask whether the magnitude of IFN-I signaling influences CD4⁺ T cell memory differentiation. I hypothesize that IFN-I modifies CD4⁺ T memory differentiation and function upon secondary infection. I will test this hypothesis using a novel mouse system with variable IFN-I signaling that includes both an established mutant with enhanced IFN-I activity and a new mouse line I generated with attenuated signaling. By immunizing and infecting these mice, I will assess how tunable IFN-I responses shape CD4⁺ T cell memory differentiation and function during primary and secondary immune responses. This work uses a unique model system to define how IFN-I signaling programs CD4⁺ memory T cells and influences their recall responses, providing insights that are essential for understanding adaptive immunity and for guiding the development of effective long lasting vaccines.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $50,114 )
2026	2026	NEW YORK UNIVERSITY	550 1ST AVE	NEW YORK	NY	10016	NEW YORK	USA	Allergy and Infectious Diseases Research	000	1	8/25/2026	NEW	$50,114
														Subtotal = $50,114

Grand Total All Awards = $50,114

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigating the effect of variable interferon signaling on CD4+ T cells

Award Number: F31AI203423

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 02/25/2027

PERIOD OF PERFORMANCE END DATE: 02/24/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer